| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.089 | 0.5 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |